药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Formebolone
Linaclotide
The therapeutic efficacy of Linaclotide can be decreased when used in combination with Emopamil.
Formebolone
Emodin
The therapeutic efficacy of Emodin can be decreased when used in combination with Emopamil.
Formebolone
Phenolphthalein
The therapeutic efficacy of Phenolphthalein can be decreased when used in combination with Emopamil.
Formebolone
Oxyphenisatin
The therapeutic efficacy of Oxyphenisatin can be decreased when used in combination with Emopamil.
Formebolone
Dantron
The therapeutic efficacy of Dantron can be decreased when used in combination with Emopamil.
Formebolone
Sorbitol
The therapeutic efficacy of Sorbitol can be decreased when used in combination with Emopamil.
Formebolone
Zinc
The therapeutic efficacy of Zinc can be decreased when used in combination with Emopamil.
Formebolone
Bifonazole
The therapeutic efficacy of Bifonazole can be increased when used in combination with Emopamil.
Formebolone
Albaconazole
The therapeutic efficacy of Albaconazole can be increased when used in combination with Emopamil.
Formebolone
Ravuconazole
The therapeutic efficacy of Ravuconazole can be increased when used in combination with Emopamil.
Formebolone
Abafungin
The therapeutic efficacy of Abafungin can be increased when used in combination with Emopamil.
Formebolone
Arotinolol
The risk or severity of hypotension can be increased when Arotinolol is combined with Emopamil.
Formebolone
Loxoprofen
The risk or severity of hyperkalemia can be increased when Loxoprofen is combined with Emopamil.
Formebolone
Carbaspirin calcium
The risk or severity of hyperkalemia can be increased when Carbaspirin calcium is combined with Emopamil.
Formebolone
Guacetisal
The risk or severity of hyperkalemia can be increased when Guacetisal is combined with Emopamil.
Formebolone
Nitroaspirin
The risk or severity of hyperkalemia can be increased when Nitroaspirin is combined with Emopamil.
Formebolone
Quinaprilat
The risk or severity of hyperkalemia can be increased when Emopamil is combined with Quinaprilat.
Formebolone
Perindoprilat
The risk or severity of hyperkalemia can be increased when Emopamil is combined with Perindoprilat.
Formebolone
Ramiprilat
The risk or severity of hyperkalemia can be increased when Emopamil is combined with Ramiprilat.
Formebolone
Benazeprilat
The risk or severity of hyperkalemia can be increased when Emopamil is combined with Benazeprilat.